Why Precipio, Inc.’s (PRPO) Stock Is Down 13.32%
As of Friday, May 15, Precipio, Inc.’s PRPO share price has dipped by 13.32%, which has investors questioning if this is right time to buy.Jenna Brashear
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
COMPANY SUMMARY
Precipio, Inc., a healthcare biotechnology company, provides cancer diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers HemeScreen, a suite of robust genetic diagnostic panels; and IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages. It offers biomarker testing and clinical project services to bio-pharma customers. Precipio, Inc. is based in New Haven, Connecticut.
Commentary & Analysis
Why Precipio, Inc.’s (PRPO) Stock Is Down 10.84%
As of Friday, May 15, Precipio, Inc.’s PRPO share price has dipped by 10.84%, which has investors questioning if this is right time to buy.Rosalio Madrigal
Why Precipio, Inc.’s (PRPO) Stock Is Down 6.66%
As of Monday, May 11, Precipio, Inc.’s PRPO share price has dipped by 6.66%, which has investors questioning if this is right time to buy.Cynthia McLaughlin
Why Precipio, Inc.’s (PRPO) Stock Is Down 5.15%
As of Tuesday, April 21, Precipio, Inc.’s PRPO share price has dipped by 5.15%, which has investors questioning if this is right time to buy.Michael Rose
Why Precipio, Inc.’s (PRPO) Stock Is Down 5.47%
As of Friday, March 13, Precipio, Inc.’s PRPO share price has dipped by 5.47%, which has investors questioning if this is right time to buy.Cynthia McLaughlin
Financial Summary
| Share Statistics | PRPO | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $37.4 | $1,875.0 | 14% |
|
| Shares Out (Mil) | 1.8 | 77.1 | 7% |
|
| Institutional Ownership | 40.3% | 88.9% | 17% |
|
| Float (Mil) | 1.4 | 50.3 | 3% |
|
| Beta | 1.30 | 0.86 | 75% |
|
| Avg Daily Volume (000s) | 123 | 466 | 38% |
|
| Price Change (52-week) |
45.3% | 78.5% | 78% |
|
| Growth | PRPO | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | 31.5% | 10.9% | 90% |
|
| Net Income (5yr) | 48.1% | (1.1%) | 93% |
|
| EPS (5yr) | 57.8% | 3.0% | 95 |
|
| Dividends (5yr) | 0.0% | 0.0% | 0% |
|
| Cash Flow (5yr) | (18.4%) | (18.2%) | 37% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | na | na | na | |
| Current EPS | na | na | na | |
| Month Ago EPS | na | na | na | |
| # Rev Up | na | na | na | |
| # Rev Down | na | na | na | |
| Three Months Ago EPS | na | na | na | |
| Year/Year Chg | na | na | na | |
| Financials | PRPO | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $26 | $1,464 | 15% |
|
| Net Income (TTM) (Mil) | ($1) | $15 | 38% |
|
| EPS (TTM) | ($0.550) | $0.300 | 27% |
|
| Operating Cash Flow (TTM) (Mil) | $1 | $138 | 33% |
|
| Net Cash Flow (TTM) (Mil) | $2 | $7 | 48% |
|
| Long-Term Debt (Q1) (Mil) | $3 | $323 | 21% |
|
| Enterprise Value (Q1) (Mil) | $41 | $2,130 | 15% |
|
| Valuation | PRPO | Industry Median |
Percentile (All Stocks) |
|
| P/B | 2.63 | 2.90 | 61% |
|
| P/E | na | 26.8 | na |
|
| Dividend Yield | 0.0% | 0.0% | 0% |
|
| PEG (5yr hist) | na | 1.1 | na |
|
| Ratios | PRPO | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 43.7% | 27.6% | 54% |
|
| Net Margin | (3.6%) | 1.1% | 27% |
|
| ROA | (4.8%) | 1.8% | 30% |
|
| ROE | (7.1%) | 6.9% | 29% |
|
| Liabilities to Assets | 31.9% | 60.0% | 23% |
|
| F-Score | 6 | 5 | 69% |
|
Precipio, Inc. did not pass any screens on 7/30/2026.
